The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
Achira is engaged in development and commercialization of PoC medical test kits in India
Piramal Pharma has reported total income of Rs. 2,578.74 crores during the period ended March 31, 2024
the campaign emphasizes the brand's reliability and effectiveness in providing timely relief
New data for Tezspire and Breztri demonstrate AstraZeneca’s innovation and commitment to transform care in COPD
Mirabegron Extended-Release Tablets, 25 mg had estimated annual sales of US$ 1,019 million in the US
Zydus is among the first suppliers to launch the generic version of Mirabegron Extended-Release Tablets, USP 25 mg in the US market
The company had earlier announced about the approval received from the MHRA for Liraglutide
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Subscribe To Our Newsletter & Stay Updated
